A Model to Determine Absolute Risk for Esophageal Adenocarcinoma
- 1 February 2013
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 11 (2) , 138-144.e2
Abstract
No abstract availableKeywords
Funding Information
- Australian Postgraduate Award (University of Queensland) and the Cancer Council New South Wales Strategic Research Partnership (08-04)
This publication has 17 references indexed in Scilit:
- American Gastroenterological Association Technical Review on the Management of Barrett's EsophagusGastroenterology, 2011
- Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort studyGut, 2010
- Comparison of discriminatory power and accuracy of three lung cancer risk modelsBritish Journal of Cancer, 2010
- Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?Gut, 2009
- Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977–2005British Journal of Cancer, 2009
- Do low control response rates always affect the findings? Assessments of smoking and obesity in two Australian case‐control studies of cancerAustralian and New Zealand Journal of Public Health, 2009
- Colorectal Cancer Risk Prediction Tool for White Men and Women Without Known SusceptibilityJournal of Clinical Oncology, 2009
- Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagusGut, 2007
- Identifying Individuals at High Risk of Melanoma: A Practical Predictor of Absolute RiskJournal of Clinical Oncology, 2006
- Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined AnnuallyJNCI: Journal of the National Cancer Institute, 1989